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Successful treatment of ischemic VT, including by catheter ablation, requires
accurate interpretation of the local electrograms. Diastolic potentials may be
recorded over a wide area of the endocardium. This study investigated the
relationship of the return pathway in VT to the area displaying diastolic ac-
tivity. 78 VTs in 30 patients were mapped endocardially at time of surgery.
Complete return pathways were seen in 17 VTs of 10 patients. The return
pathway was defined by tracking diastolic potentials from the earliest dias-
tolic signal towards the site of VT origin. Conduction time over the return
pathway represented the diastolic interval. The area of diastolic activity was
determined by calculating the area enclosed by electrodes showing diastolic
potentials from an inflated endocardial balloon.
Result: The mean return pathway conduction time was 90 ± 31 ms (range
40--140 ms). Mean diastolic interval was 64 ± 23 ms Irange 30-115 ms). The
mean area over which diastolic activity could be seen was 317 ± 255 mm2
(range 28-920 mm2). In all 17 VTs, diastolic activity was seen within 15 mm
of site of origin, and this represented an area of 98 ± 65 mm2 (range 28-170
mm2). 62% local electrograms within 15 mm of site of origin showed a dias-
tolic potential to GRS interval < 70 ms. All patients with such a pattern were
cured by surgery, but 2 of 4 patients with diastolic potential to GRS interval
~70 ms had VT recurrence. VT cycle length correlated with the conduction
time of return pathway (R ~ 0.765, p = 0.0002), but not with the area of the
retu rn pathway.
Implication: 1) Region exhibiting diastolic potentials was far greater than
the return pathway per se. 2) Characterization of the timing of diastolic po-
tentials relative to the GRS complex helps to identify critical portions of the
return pathway close to the VT site of origin. 3) Such analysis may differen-
tiate critical areas of the return pathway from bystander regions. 4) These
observations may help direct radio-frequency ablation in the catheter labora-
tory.
37 Irange 6-64) years (yrs), and mean follow-up of 24 (range 1-51) months,
including 30 pts with >2 yrs follow-up. Symptoms prior to ablation were
presyncope (27 pts), palpitations (21 pts), syncope (8 pts), and chest pain (1
pt). The mean duration of symptomatic VT prior to ablation was 4.2 yrs (range
6wks.-25 yrs.). A mean of 2.3 (range 1-6) drug trials failed to suppress VT. VT
mapped to the right ventricular outflow tract (RVOT) in 36 of the 58 pts. Four-
teen of 22 non-RVOT VTs mapped to the left ventricle (LV) and 8 mapped
to the right ventricle (RV) 16 RV inflow; 2 RV free wall). Eight of 14 LV VTs
were left posterior fascicular. RFCA targeting non-fascicular VTs was guided
by the earliest endocardial activation time and pace mapping. Fascicular VT
was guided by early Purkinje potentials. Overall, RFCA eliminated VT in 49 of
57 (86%) pts. In patients with RVOT VT, RFCA eliminated VT in 35/35 (100%)
pts. Non-RVOT VT was successfully ablated in 14/22 (63%) pts, including 7/8
(88%) with left posterior fascicular VT. Two pts required 2 RFCA sessions for
success (1 RVOT and 1 non-RVOT). Two pts were treated for post-procedure
pericardia I effusions and one developed a transient segmental wall motion
abnormality. During follow-up, no patient had spontaneous or inducible VT
or died. Conclusion: 1.) RFCA for idiopathic VT is feasible and safe in a large
patient cohort. 2.) The success rate is higher for RVOT VT. 3.) Neither late
recurrence nor proarrythmia has been observed.
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An intraventricular conduction delay (IVCD) may influence the efficacy and
safety of antiarrhythmic (AA) drugs. The Cardiac Arrhythmia Suppression
Trial (CAST) allows assessment of the influence of an IVCD on survival when
AA drugs are used following a myocardial infarction IMI). In CAST, MI pa-
tients with frequent ventricular premature depolarization (VPDs) laveraging
28 VPD/H) were randomized to receive an AA drug (flecainide, encainide or
moricizine) or a placebo. After therapy was started 956 patients (35%) had
an IVCD (GRS :': 0.11 sec) and 1796 patients (65%) had a GRS < 0.11 sec.
Patients IVCD patients differed from those with normal conduction by: be-
ing older (72% > age 60 vs. 54%); more often having an ejection fraction
<0.30 130% vs. 21 %); more often having >50 VPD/H at baseline (51 % vs.
43%): and having more pre-CAST Mis (45% vs. 38%) (P < 0.001 for each).
Mean follow-up was 1.1 years.
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Conclusions: Slow intraatrial tachycardias may be observed in symp-
tomatic post-maze patients. Our findings are consistent with slow conduc-
tion and reentry along a line of conduction block. Radiofrequency catheter
ablation can be curative for these tachycardias.
John M. Mandroia, Lawrence S. Klein, William M. Miles, David P Rardon, Raul
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Indianapolis, Indiana
Several centers have reported successful radiofrequency catheter ablation
(RFCA) of ventricular tachycardia (VT) in patients (pts) without structural
heart disease (idiopathic VT). Long term follow-up, however, has not been
reported. We performed RFCA in 57 pts (23 females) with a mean age of
Anatomical sequelae after creation of right atrial myocardial lesions by ra-
diofrequency current (RFC) application have not been studied in detail in
young subjects. During general anesthesia, a steerable 6 French electrode
catheter, equipped with a thermistor at the 4 mm tip electrode, was posi-
tioned at the lateral atrial aspect of the tricuspid valve anulus in 10 piglets
(german landrace, age 6 weeks, mean body weight 12.5 kg). RFC (500 kHz)
was delivered temperature-guided (75 'C) over 30 sec. Right atrial RFC le-
sions were studied macroscopically and microscopically in 5 animals after
48 hours, the remaining 5 animals were examined after 6 months.
After 48 hours, RFC lesions presented as transmural grey-white coagula-
tion necrosis. Lesions were sharply demarcated by a lymphocytic wall. Lym-
phocytic infiltration around the lesions extended to the right coronary artery
in 4/5 animals and to right ventricular myocardium in 3/5 piglets.
After 6 months, lesions consisted of transmural white scar tissue extend-
ing to the right ventricular myocardium in 2/5 animals. Layers of the right
coronary artery were affected in 4/5 pigs. In 2 animals, the lumen of the right
coronary artery was obstructed due to intimal thickening by 25 and 40%,
respectively.
Conclusion: Results should be taken into account when radiofrequency
current application at the atrial aspect of the tricuspid valve anulus is consid-
ered in infants and small children.
James M. Kleman, Richard Sterba, Gregory A. Kidwell. The Cleveland ClInic
Foundation, Cleveland, OH
The maze procedure is a surgical alternative for treating drug refractory atrial
fibrillation. Although post-maze atrial fibrillation has been noted, slow intraa-
trial tachycardias have not been reported. Of 31 maze patients with a mean
follow-up of 22 ± 9 months, 6 underwent electro physiologic (EP) testing (9
± 6 months post-op) for symptoms suggestive of recurrent arrhythmia. Re-
sults: Conduction was significantly prolonged through the right compared
to the left atrium (167 ± 44 vs 57 ± 10 ms, p < 0.01). However, right atrial
effective refractory periods were normal (237 ± 29 msl. Programmed atrial
stimulation induced sustained slow intraatrial reentry in two patients (cycle
lengths of 420 and 520 ms) and atrial flutter (cycle length 190 ms) in one
patient. The slow reentrant tachycardias were successfully ablated with ra-
diofrequency energy in both patients. Neither patient has experienced a clin-
ical recurrence after 14 and 9 months. Electrograms at successful ablation
sites were markedly fragmented during sinus rhythm, with an apparent re-
versal of near/far-field activation during tachycardia (see figure).
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